NIVF (NewGenIvf Group) Scaled Net Operating Assets: 0.85 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NIVF NewGenIvf Group Ltd NIVF
14 GF Score
Price $1.12
! 4 Warning Signs
View Full Analysis

What is NewGenIvf Group Scaled Net Operating Assets?

NewGenIvf Group NIVF -9.09% 14 Scaled Net Operating Assets is 0.85 as of Dec. 2025. GuruFocus rates NIVF with a GF Score™ of 14/100. The stock has 4 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

NewGenIvf Group's operating assets for the quarter that ended in Dec. 2025 was $31.96 Mil. NewGenIvf Group's operating liabilities for the quarter that ended in Dec. 2025 was $1.87 Mil. NewGenIvf Group's Total Assets for the quarter that ended in Sep. 2025 was $35.56 Mil. Therefore, NewGenIvf Group's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2025 was 0.85.


NewGenIvf Group Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for NewGenIvf Group's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NewGenIvf Group Scaled Net Operating Assets Chart

NewGenIvf Group Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Scaled Net Operating Assets
-0.01 0.37 1.21 0.24 8.41

NewGenIvf Group Quarterly Data
Dec21 Dec22 Jun23 Dec23 Sep24 Dec24 Jun25 Sep25 Dec25
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only 0.00 0.00 3.25 2.29 0.85

NIVF vs RHEP, XCRT, SYRA: Scaled Net Operating Assets Comparison

For the Medical Care Facilities subindustry, NewGenIvf Group's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NewGenIvf Group Scaled Net Operating Assets vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NewGenIvf Group's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where NewGenIvf Group's Scaled Net Operating Assets falls into.


NIVF
14GF Score
NewGenIvf Group Ltd NIVF
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NewGenIvf Group Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

NewGenIvf Group's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(31.964-1.872)/3.578
=8.41

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=32.723 - 0.759
=31.964

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=6.736 - 4.37 - 0.494
=1.872

NewGenIvf Group's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2025 )
=(Operating Assets (Q: Dec. 2025 )-Operating Liabilities (Q: Dec. 2025 ))/Total Assets (Q: Sep. 2025 )
=(31.964-1.872)/35.558
=0.85

where

Operating Assets(Q: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=32.723 - 0.759
=31.964

Operating Liabilities(Q: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=6.736 - 4.37 - 0.494
=1.872

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.85 mean?
NewGenIvf Group (NIVF) has a Scaled Net Operating Assets of 0.85 as of Dec. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on NewGenIvf Group and its competitors.
Is NewGenIvf Group's Scaled Net Operating Assets too high?
NewGenIvf Group's current Scaled Net Operating Assets is 0.85. Overall, NewGenIvf Group has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does NewGenIvf Group's Scaled Net Operating Assets compare to RHEP and XCRT?
NewGenIvf Group's Scaled Net Operating Assets of 0.85 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Healthcare Providers & Services company?
A good Scaled Net Operating Assets depends on the Healthcare Providers & Services industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on NewGenIvf Group and its competitors. NewGenIvf Group's current Scaled Net Operating Assets is 0.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewGenIvf Group stock overvalued right now?
NewGenIvf Group (NIVF) has a current Scaled Net Operating Assets of 0.85. The current Scaled Net Operating Assets is 0.85. NewGenIvf Group's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For NewGenIvf Group (NIVF), the current Scaled Net Operating Assets is 0.85 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NewGenIvf Group Business Description

Address Sukhumvit 21 Road, Asoke, 36/39-36/40, 13th Floor, PS Tower, Khlong Toei Nuea Sub-district, Watthana District, Bangkok, THA, 10110
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
14GF Score

Get the complete analysis for NIVF

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.12
Price